Deccan Health Care Limited, a nutraceutical company provides nutritional, personal care, and food-based solutions. It produces and distributes soft gelatin capsules, food pills, vitamin supplements, and nutritional meals. The company also provides capsules, tablets, soft gels, powders, liquids, and gummies. Deccan Health Care Limited was incorporated in 1996 and is based in Hyderabad, India.
Rs. Crores · hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales 21.86
20.26
23.03
24.40
21.47
20.82
20.43
18.82
15.06
15.97
15.34
17.19
11.22
Expenses 21.02
19.49
21.35
22.69
20.75
20.19
19.83
17.70
14.19
15.31
14.10
16.16
10.40
Operating Profit 0.84
0.77
1.68
1.71
0.72
0.63
0.60
1.12
0.87
0.66
1.24
1.03
0.82
OPM % 3.84
3.80
7.29
7.01
3.35
3.03
2.94
5.95
5.78
4.13
8.08
5.99
7.31
Other Income 0.03
0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.01
0.00
0.00
0.01
Depreciation 0.39
0.38
0.35
0.33
0.41
0.36
0.37
0.37
0.36
0.36
0.40
0.32
0.39
Interest 0.16
0.14
0.04
0.16
0.02
0.02
0.02
0.03
0.02
0.02
0.02
0.00
0.02
Profit before tax 0.32
0.25
1.29
1.22
0.30
0.25
0.21
0.72
0.49
0.29
0.82
0.71
0.42
Tax % 25.00
8.00
26.36
26.23
30.00
44.00
23.81
25.00
26.53
58.62
32.93
25.35
26.19
Net Profit 0.25
0.23
0.95
0.90
0.21
0.14
0.16
0.54
0.37
0.13
0.55
0.53
0.31
EPS in Rs 0.10
0.09
0.38
0.36
0.08
0.06
0.07
0.26
0.18
0.06
0.27
0.31
0.18
Annual · Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2010
Sales
89.17 75.13 59.73 45.02 33.17 33.78 42.24 44.25 37.83 29.34 16.16 39.52
Expenses
84.29 71.95 55.97 42.97 27.54 31.74 30.57 27.44 23.77 16.54 9.81 38.54
Operating Profit
4.88 3.18 3.76 2.05 5.63 2.04 11.67 16.81 14.06 12.80 6.35 0.98
OPM %
5.47 4.23 6.29 4.55 16.97 6.04 27.63 37.99 37.17 43.63 39.29 2.48
Other Income
0.01 0.01 0.01 0.02 -3.46 0.06 0.06 0.08 2.07 0.05 -0.17 0.09
Interest
0.37 0.07 0.06 0.11 0.15 0.11 0.18 1.04 1.50 2.14 1.48 0.10
Depreciation
1.46 1.45 1.47 1.43 1.47 1.47 1.42 1.29 1.28 1.19 1.15 0.22
Profit before tax
3.06 1.67 2.24 0.53 0.55 0.52 10.13 14.56 13.35 9.52 3.55 0.75
Tax %
25.16 28.14 32.59 26.42 40.00 25.00 0.39 0.62 -0.15 -0.21 0.28 30.67
Net Profit
2.29 1.20 1.52 0.40 0.32 0.39 10.09 14.48 13.36 9.54 3.54 0.53
EPS in Rs
0.93 0.51 0.75 0.23 0.20 0.25 6.42 9.22 9.90 7.38 3.39 0.99
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2010
Equity Capital
24.75 23.43 20.38 17.04 15.71 15.71 15.71 15.71 13.50 12.93 10.43 5.33
Reserves
85.47 83.13 76.66 64.61 61.23 60.91 60.52 50.43 32.68 9.21 -2.03 11.08
Borrowings
3.96 1.15 1.41 1.55 1.25 1.03 1.30 1.41 10.90 10.94 13.94 10.46
Other Liabilities
29.94 16.22 8.87 13.28 12.44 14.61 15.46 15.30 13.40 16.51 7.00 3.29
Total Liabilities
144.12 123.93 107.32 96.48 90.63 92.26 92.99 82.85 70.48 49.59 29.34 30.16
Fixed Assets
15.02 14.38 15.69 16.85 18.53 19.87 21.25 20.85 17.71 17.32 17.12 18.54
CWIP
0.00 0.00 0.00 0.00 0.00 0.07 0.00 0.00 3.51 0.00 0.00 0.00
Investments
0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.00 0.00
Other Assets
129.09 109.54 91.62 79.62 72.09 72.31 71.74 62.00 49.26 32.25 12.22 11.62
Total Assets
144.12 123.93 107.32 96.48 90.63 92.26 92.99 82.85 70.48 49.59 29.34 30.16
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2010
Cash from Operating Activity
-3.59 -6.60 -12.48 -6.59 -0.57 0.22 2.68 2.62 12.92 2.28 3.04 0.00
Cash from Investing Activity
-2.25 -0.14 -0.30 0.26 -0.05 -0.08 -1.94 -11.53 -12.90 -1.40 0.00 0.00
Cash from Financing Activity
3.97 8.01 13.64 5.06 0.07 -0.37 -1.77 13.07 0.21 -0.95 -2.91 0.00
Net Cash Flow
-1.87 1.27 0.86 -1.27 -0.55 -0.23 -1.03 4.16 0.23 -0.08 0.13 0.00
Free Cash Flow
-5.83 -6.74 -12.79 -6.34 -0.63 0.06 0.87 1.70 7.74 0.88 3.04 0.00
CFO/OP %
-73.00 -207.00 -332.00 -311.00 -6.00 18.00 23.00 16.00 92.00 18.00 48.00 0.00
Annual · Days / % — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2010
Debtor Days
97.09 61.26 60.44 97.21 141.07 134.74 177.66 159.86 170.49 229.90 181.82 50.24
Inventory Days
239.32 326.33 445.05 683.64 1,182.75 890.81 825.88 773.64 596.97 432.36 269.62 34.08
Days Payable
99.44 68.52 41.39 123.28 146.00 112.09 153.84 185.88 173.22 447.94 264.36 31.06
Cash Conversion Cycle
236.98 319.07 464.10 657.58 1,177.82 913.46 849.70 747.62 594.24 214.32 187.08 53.25
Working Capital Days
384.77 423.69 477.19 502.26 603.01 545.99 421.77 321.94 240.82 193.82 -155.17 51.72
ROCE %
3.09 1.69 2.53 0.79 5.62 0.81 14.21 25.03 32.94 42.08 — 5.08
% holding — latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
19.46
19.46
18.42
18.42
18.42
19.46
18.26
15.66
16.12
16.12
16.12
19.27
DIIs
5.68
5.68
5.37
5.37
5.37
5.68
5.87
6.34
6.53
6.53
6.53
7.80
Public
74.86
74.87
76.20
76.21
76.20
74.87
75.89
78.02
77.35
77.35
77.35
72.92
No. of Shareholders
4,084
4,004
3,926
3,743
3,667
3,614
3,416
3,154
3,002
2,737
2,041
1,645